Source:http://linkedlifedata.com/resource/pubmed/id/19287309
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-4-8
|
pubmed:abstractText |
Caveolin 1 (cav-1) is the basic component of the flask-shaped membrane microdomains known as caveolae that are involved in various cell functions. Caveolin 1 can be overexpressed in tumors,suggesting a proneoplastic role, or it can be downregulated. We previously reported that cav-1 expression increases with tumor grade in astrocytomas. Here, we studied cav-1 immunoreactivity in brain umors with an oligodendroglial component to determine the prognostic value of cav-1 expression and to correlate it with 1p/19q deletions. Fifty-four oligodendrogliomas, 26 mixed oligoastrocytomas,and 7 glioblastomas with an oligodendroglial component were assessed for cav-1 expression by immunohistochemistry and for 1p/19q status by fluorescence in situ hybridization. Caveolin-1 was detected in a minority of cases (22%) and was associated mostly with Grade III mixed oligoastrocytomas and glioblastomas with anoligodendroglial component; cav-1 expression was significantly correlated with the absence of a 1p/19q deletion (p = 0.0002). In the 63 cases in which survival data were available, cav-1 expression was also significantly associated with shorter survivals, whereas 1p/19q deletion was associated with longer survivals. Among high-grade tumors, cav-1 expression was the only factor that retained a statistical significance after multivariate analysis for the prediction ofa short survival (p G 0.015). These data are the first evidence that cav-1 immunohistochemistry is an independent prognostic marker in tumors with an oligodendroglial component regardless of the 1p/19q status.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-3069
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
425-31
|
pubmed:meshHeading |
pubmed-meshheading:19287309-Brain Neoplasms,
pubmed-meshheading:19287309-Caveolin 1,
pubmed-meshheading:19287309-Chromosome Deletion,
pubmed-meshheading:19287309-Chromosomes, Human, Pair 1,
pubmed-meshheading:19287309-Female,
pubmed-meshheading:19287309-Follow-Up Studies,
pubmed-meshheading:19287309-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19287309-Humans,
pubmed-meshheading:19287309-Male,
pubmed-meshheading:19287309-Oligodendroglioma,
pubmed-meshheading:19287309-Retrospective Studies,
pubmed-meshheading:19287309-Survival Analysis
|
pubmed:year |
2009
|
pubmed:articleTitle |
Caveolin 1 expression independently predicts shorter survival in oligodendrogliomas.
|
pubmed:affiliation |
Department of Biomedical Sciences, University of Turin, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|